Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 20 of 102 for “"Current therapy"”.

  1. Η ΘΕΡΑΠΕΥΤΙΚΗ ΕΠΙΔΡΑΣΙΣ ΤΩΝ ΚΟΡΤΙΚΟΣΤΕΡΟΕΙΔΩΝ ΣΤΟΥΣ ΠΝΕΥΜΟΝΕΣ ΠΕΙΡΑΜΑΤΟΖΩΩΝ ΜΕ ΟΞΕΙΑ ΠΑΓΚΡΕΑΤΙΤΙΔΑ. ΠΕΙΡΑΜΑΤΙΚΗ ΜΕΛΕΤΗ ΣΕ ΚΥΝΕΣ

    … IN THREE GROUPS. IN THE FIRST GROUP WE GAVE THE CURRENT THERAPY AND HIGH DOSE CORTICOSTEROIDS (METHLYLPREDNISOLONE 30 MGR/KGR OF BODY WEIGHT), IN THE SECOND ONLY THE CURRENT THERAPY AND IN THE THIRD GROUP ONLY DEXTROSE 5% IV SERUM. TO ALL GROUPS WE STUDIED BIOCHEMICAL PARAMETERS, THE ACTIVATION …

    greece Repository record for Η ΘΕΡΑΠΕΥΤΙΚΗ ΕΠΙΔΡΑΣΙΣ ΤΩΝ ΚΟΡΤΙΚΟΣΤΕΡΟΕΙΔΩΝ ΣΤΟΥΣ ΠΝΕΥΜΟΝΕΣ ΠΕΙΡΑΜΑΤΟΖΩΩΝ ΜΕ ΟΞΕΙΑ ΠΑΓΚΡΕΑΤΙΤΙΔΑ. ΠΕΙΡΑΜΑΤΙΚΗ ΜΕΛΕΤΗ ΣΕ ΚΥΝΕΣ (opens in a new tab)

  2. Investigating therapy in the rehabilitation of physical function after severely disabling stroke- a mixed methods study.

    … of physical function, which involves physiotherapy and occupational therapy, does not fully address the sequelae of severely disabling stroke. However, there is a paucity of research to identify what current therapy practice involves, how rehabilitation interventions are decided upon, and …

    kings Repository record for Investigating therapy in the rehabilitation of physical function after severely disabling stroke- a mixed methods study. (opens in a new tab) Download PDF for Investigating therapy in the rehabilitation of physical function after severely disabling stroke- a mixed methods study. (opens in a new tab)

  3. Development of an adenoviral vector vaccine for Rhodococcus equi

    … mature enough to combat an R. equi infection. Current therapy for R. equi infection consists of long-term combination antimicrobial treatment, but antibiotic resistance in R. equi is emerging. Thus it is important to find an efficacious vaccine for the prevention of R. equi disease in foals.

    adelaide Repository record for Development of an adenoviral vector vaccine for Rhodococcus equi (opens in a new tab)

  4. Drug Discovery and Structural Studies on Mycobacterium tuberculosis Proteins Related to Drug Resistance and Persistence

    … the leading infectious diseases worldwide. The current therapy for drug-sensitive TB is complex and lasts for at least six months. Improper use of antibiotics during this regimen has led to the emergence of drug resistance, which represents a grave threat to human health. This problem is further …

    tamu Repository record for Drug Discovery and Structural Studies on Mycobacterium tuberculosis Proteins Related to Drug Resistance and Persistence (opens in a new tab)

  5. A Meta-Analysis of Hydroxyurea Use for β-thalassemia: Implications for Clinical Practice and Medical Education

    … may prevent some of the problems associated with current therapy. Hydroxyurea (HU), an oral chemotherapeutic drug, is expected to increase hemoglobin, thereby minimizing the burden of blood transfusion and its complications. The objective of this study was to conduct a systematic review and …

    calgary Repository record for A Meta-Analysis of Hydroxyurea Use for β-thalassemia: Implications for Clinical Practice and Medical Education (opens in a new tab)

  6. Development of new human stem cell - derived cellular vehicles for glioma gene therapy

    … most lethal forms of cancer in humans. However, current therapy for glioma rarely achieves long-term tumor control. Stem cell-based gene therapy is a promising new strategy for the treatment of glioma. Neural stem cells are highly efficacious in targeting brain tumors and show a specific affinity …

    nus Repository record for Development of new human stem cell - derived cellular vehicles for glioma gene therapy (opens in a new tab) Download file for Development of new human stem cell - derived cellular vehicles for glioma gene therapy (opens in a new tab)

  7. Design, Development and Evaluation of a Software Tool for Therapy Planning of Non-invasive Cardiac Radioablation for Treatment of Ventricular Tachycardia

    … cardiac radioablation (RA) is an emerging therapy for the treatment of ventricular tachycardia (VT). Electrophysiologic, anatomic and molecular imaging studies are used to localize the breakout region of the VT, but current therapy planning is tedious and prone to error due to a lack of …

    carleton Repository record for Design, Development and Evaluation of a Software Tool for Therapy Planning of Non-invasive Cardiac Radioablation for Treatment of Ventricular Tachycardia (opens in a new tab)

  8. C. elegans as a model organism for organophosphate nerve agent investigations

    … lethality due to cessation of breathing. Current treatment relies on drugs that act against the overstimulation of muscarinic acetylcholine receptors and enhancing inhibitory GABAergic signalling to combat central nervous system excitability. Whilst a major determinant of the exposure is …

    soton Download PDF for C. elegans as a model organism for organophosphate nerve agent investigations (opens in a new tab)

  9. Breast carcinoma in situ types, diagnostics, treatment and prognosis /

    … biological and clinical potential. The goal of therapy management with surgery, radiation therapy and endocrine therapy is to prevent local recurrence and progression to invasive disease. This is increasingly a great challenge to understand the natural history of in situ lesions and to find …

    vilnius Repository record for Breast carcinoma in situ types, diagnostics, treatment and prognosis / (opens in a new tab)

  10. Probiotic potency of butyrate-producing bacteria for modulating the microbiome and epithelial barrier in inflammatory bowel disease

    … strategy to control the disease and to support current therapy. Butyrate-producing bacteria are considered as the future probiotics for IBD because butyrate has anti-inflammatory functions and has the capacity to strengthen the intestinal barrier. Before setting up clinical trials in humans with …

    ghent Repository record for Probiotic potency of butyrate-producing bacteria for modulating the microbiome and epithelial barrier in inflammatory bowel disease (opens in a new tab)

  11. Semi-preparative expression and purification of a recombinant glucocerebrosidase protein with a PTD4 transduction domain: a potential therapeutic strategy for neuronopathic Gaucher’s disease.

    … as well as neurological symptoms. Current enzyme replacement therapy is effective in treating visceral symptoms but cannot cross the blood-brain barrier to target neurological manifestations. Another drawback to current therapy is the high cost to patients due to present protein …

    uvic Repository record for Semi-preparative expression and purification of a recombinant glucocerebrosidase protein with a PTD4 transduction domain: a potential therapeutic strategy for neuronopathic Gaucher’s disease. (opens in a new tab)

  12. Investigating the Pathogenesis and Response to Therapy of Cerebral Cavernous Malformations Using Transgenic Murine Models

    … neurologic deficits, seizures, headaches, and recurrent hemorrhages. Current therapy for CCMs consists of surgical removal in select cases and symptom management. There is no medical therapy to treat the underlying pathology in this disease. CCMs develop following biallelic loss-of-function …

    duke Repository record for Investigating the Pathogenesis and Response to Therapy of Cerebral Cavernous Malformations Using Transgenic Murine Models (opens in a new tab)

  13. MODULATION OF CYCLIC ADENOSINE MONOPHOSPHATE FOR POTENTIATION OF LONG-ACTING β2-AGONIST AND GLUCOCORTICOIDS IN HUMAN AIRWAY EPITHELIAL CELLS

    … how to treat and manage the symptoms of asthma, current therapy is sub-optimal in 35-50% of moderate-severe asthmatics around the world resulting in lung inflammation, persistent impairment of lung function, and increased risk of mortality. Combination of long-acting β2 agonists (LABA) for …

    mcmaster Repository record for MODULATION OF CYCLIC ADENOSINE MONOPHOSPHATE FOR POTENTIATION OF LONG-ACTING β2-AGONIST AND GLUCOCORTICOIDS IN HUMAN AIRWAY EPITHELIAL CELLS (opens in a new tab)

  14. Aromatherapy in Substance Withdrawal Treatment Programs in Adults: A Systematic Review [paper]

    … resulting in difficulty in ensuring abstinence. Current therapy has proven to be successful, but providers seek to incorporate integrative therapies as adjunctive therapy. This systematic review examines and evaluates the effectiveness of aromatherapy compared with the standard treatment of care …

    texas-state Repository record for Aromatherapy in Substance Withdrawal Treatment Programs in Adults: A Systematic Review [paper] (opens in a new tab)

  15. Participation-focused intervention among US speech language pathologists

    … refers to evaluating clients and establishing therapy programs that emphasize helping clients achieve optimal participation in their life activities such as work, household management, social relationships, and community activities. <italic>Purpose</italic>: To investigate whether and how …

    washington Repository record for Participation-focused intervention among US speech language pathologists (opens in a new tab)

  16. The development of novel therapeutic vaccines for chronic hepatitis B infection

    … HBV infection, have a high mortality. Current therapy controls HBV replication but does not eradicate the virus, and therefore most people require life-long treatment. A robust adaptive immune response is required to control acute HBV but is dysfunctional in individuals that go onto …

    oxford Repository record for The development of novel therapeutic vaccines for chronic hepatitis B infection (opens in a new tab)

  17. Direct Pharmacological Targeting of Asparagine Synthetase to Overcome Resistance to L-asparaginase in ALL Therapy

    … arising from both B- and T-cell lineages. Current therapy exploits leukemia cells’ low expression of asparagine synthetase (ASNS) by using L-asparaginase, a bacterial enzyme that depletes circulating asparagine. Although L-asparaginase is generally effective, resistance can develop in some …

    iupui Repository record for Direct Pharmacological Targeting of Asparagine Synthetase to Overcome Resistance to L-asparaginase in ALL Therapy (opens in a new tab)

  18. Genomic characterization of non-small cell lung cancer - clinical and molecular implications

    … partly due to late diagnosis which limits the therapy options. Improved understanding of molecular and biological mechanisms of tumor development could guide current therapy selection or pave way for novel therapies. The aim of this thesis is to characterize non-small cell lung cancer (NSCLC) …

    lund Repository record for Genomic characterization of non-small cell lung cancer - clinical and molecular implications (opens in a new tab) Download PDF for Genomic characterization of non-small cell lung cancer - clinical and molecular implications (opens in a new tab)

  19. The Design and Synthesis of Novel Antimicrobial Agents for Use in the Battle Against Bacterial Resistance

    … for use in the United States, and looks into the current antimicrobial drug pipeline. Chapter 2 explores the current therapy regime for combating tuberculosis and expresses the need for novel agents in this arena. It also shows how current medicinal chemistry techniques are being utilized to …

    tenn-hsc Repository record for The Design and Synthesis of Novel Antimicrobial Agents for Use in the Battle Against Bacterial Resistance (opens in a new tab)

  20. Determining the role of N-cadherin in the formation of the myeloma niche

    … where they can remain dormant and protected from current therapy to eventually proliferate and cause disease progression. N-cadherin is an adhesion molecule that has been implicated in the localization of haematopoietic stem cells (HSCs) to ‘niches’ containing osteoblasts on endosteal bone …

    whiterose Repository record for Determining the role of N-cadherin in the formation of the myeloma niche (opens in a new tab) Download file for Determining the role of N-cadherin in the formation of the myeloma niche (opens in a new tab)

Page 1 of 6